SVA
NASDAQ · Biotechnology
Sinovac Biotech Ltd
$6.47
+0.00 (+0.00%)
Open$6.47
Previous Close$6.47
Day High$6.47
Day Low$6.47
52W High$6.47
52W Low$6.47
Volume—
Avg Volume0
Market Cap639.90M
P/E Ratio—
EPS$-1.25
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | |
|---|---|---|
| Revenue | 445.10M | 464.96M |
| Net Income | -99,209,845 | -93,271,555 |
| Profit Margin | -22.3% | -21.2% |
| EBITDA | -94,749,309 | -94,026,787 |
| Free Cash Flow | — | — |
| Rev Growth | -4.3% | -4.3% |
| Debt/Equity | 0.03 | 0.03 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $208.38 | -0.29% | 87.4 | 369.26B |
| AMGN | Amgen Inc | $355.30 | +1.69% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $137.64 | -0.66% | 20.2 | 172.18B |
| VRTX | Vertex Pharmaceuticals Inc | $441.20 | +1.27% | 28.2 | 111.34B |
| REGN | Regeneron Pharmaceuticals | $750.57 | +0.61% | 17.6 | 79.09B |
| ALNY | Alnylam Pharmaceuticals Inc | $309.66 | -3.27% | 134.8 | 42.29B |